SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending after reporting a massive earnings beat and an expanded $14 billion share buyback, though the stock has faced downward pressure due to investor concerns that its forward guidance fell short of aggressive expectations. The community is sharply divided, with bulls pointing to record-breaking margins and structural AI-driven demand, while bears argue the cyclical nature of memory chips and recent valuation surges make the stock vulnerable to profit-taking.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending following strong Q2 results that featured record revenue and a full-year guidance increase, sparking significant community debate over the potential for a short squeeze. Investors are closely monitoring the stock's high short interest and the successful adoption of its OASYS platform, while discussions weigh the company's growth momentum against persistent concerns regarding its path to profitability.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is facing extreme market volatility following a mixed earnings report where a slight revenue miss and cautious forward guidance triggered a sharp sell-off. While the community is debating whether the stock is a severely oversold opportunity or a sign of slowing growth in the ad-tech sector, many investors are focused on the company's strong margins, share buyback program, and the resolution of the SEC investigation as catalysts for a potential recovery.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to the final regulatory approval of its acquisition of SkyWater Technology, a strategic move aimed at vertically integrating its operations and securing a domestic semiconductor supply chain. While the stock has faced volatility, the community is heavily focused on how this manufacturing control will accelerate the company's quantum roadmap and influence upcoming earnings guidance.

Redwire Corp. engages in the development and provision of space and defense technologies and mission-critical solutions for government, commercial, and civil customers. Its offerings include spacecraft platforms, space infrastructure, avionics, sensors and payloads, power generation systems, radio frequency systems, microgravity research and manufacturing technologies, autonomous systems, optical sensors, and digital engineering solutions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp is trending as investors weigh its solid Q2 earnings performance and growing backlog against sector-wide volatility and broader concerns about space infrastructure valuations. The community is actively discussing the stock's potential for a short squeeze, its long-term defense-tech thesis, and the impact of institutional accumulation ahead of upcoming milestones.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is facing significant selling pressure as investors react to disappointing earnings, margin contraction, and concerns regarding project execution timelines. While the community remains divided, many are focused on the long-term potential of its massive $6.4 billion backlog and its role in the expanding AI data center infrastructure.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending as investors debate whether recent volatility and heavy short interest signal a potential short squeeze or an overvalued asset facing long-term competitive threats. Community discourse remains sharply divided between bulls highlighting strong revenue growth and AI integration and bears focusing on institutional insider selling and valuation concerns.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital shares are facing significant downward pressure as investors rotate out of semiconductor and memory plays, despite the company's recent earnings beat and sustained demand for AI-related storage infrastructure. Market participants are actively debating whether this sell-off is a rational repricing due to valuation concerns and macro fears regarding international competition, or an overextended reaction driven by algo-heavy institutional selling.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors focus on the upcoming Phase 2 clinical readout for ABCL635, a potential blockbuster treatment for vasomotor symptoms. The community is actively debating the company's valuation, recent pharmaceutical partnerships with firms like Jazz and Vertex, and its shift from a discovery service provider to a developer of proprietary drug assets.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as the community closely monitors the company's recent publication of pediatric safety data, which is widely viewed as a strategic move to bolster its case for pending European regulatory approval. Investors are actively debating the significance of this data alongside the company's strong cash position and the potential for a favorable shift in market valuation as it awaits the outcome of the European Medicines Agency's review process.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress

Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets...

Merck (MRK) Reports Q2 Loss, Beats Revenue Estimates

Merck (MRK) delivered earnings and revenue surprises of +50.00% and +1.69%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

AbbVie (ABBV) Q2 Earnings and Revenues Beat Estimates

AbbVie (ABBV) delivered earnings and revenue surprises of +0.28% and +1.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

AbbVie (ABBV) Moves 4.2% Higher: Will This Strength Last?

AbbVie (ABBV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Bayer (BAYRY) Moves 17.0% Higher: Will This Strength Last?

Bayer (BAYRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Innoviva, Inc. (INVA) Launches Nortiva Bio to Advance Long-Acting Oral Drug Platform

Innoviva, Inc. (INVA) Launches Nortiva Bio to Advance Long-Acting Oral Drug Platform...

Nortiva Bio Launches to Develop Long-Acting Oral Medicines

Nortiva Bio, Inc. (Nortiva) today announced its launch as a clinical-stage biopharmaceutical company dedicated to developing long-acting oral medicines using its proprietary LYNX drug delivery platform. Nortivas LYNX platform can transform daily pills into long-acting oral therapies with single...

Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddys for XACDURO in Select International Markets

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced that it has entered into an exclusive distribution and licensing agreement with Dr. Reddys Laboratories Ltd., a global pharmaceutical company, for the development and commercialization of XACDURO...

Innoviva to Participate in Upcoming Investor Conferences

Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More

Key PointsDauntless Investment Group bought 116,863 shares of Innoviva in an estimated trade of $2.52 million last quarter...

Innoviva, Inc. engages in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.

Innoviva Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.44	-$1.14	-361.47%	MISSED
Q1 '26	$0.39	$2.22	469.23%	BEAT
Q4 '25	$0.55	$1.94	252.11%	BEAT
Q3 '25	$0.46	$1.08	134.78%	BEAT
Q2 '25	$0.50	$0.77	54.30%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings